» Articles » PMID: 30871561

A Patient-centered Deprescribing Intervention for Hospitalized Older Patients with Polypharmacy: Rationale and Design of the Shed-MEDS Randomized Controlled Trial

Overview
Publisher Biomed Central
Specialty Health Services
Date 2019 Mar 16
PMID 30871561
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Polypharmacy is prevalent among hospitalized older adults, particularly those being discharged to a post-care care facility (PAC). The aim of this randomized controlled trial is to determine if a patient-centered deprescribing intervention initiated in the hospital and continued in the PAC setting reduces the total number of medications among older patients.

Methods: The Shed-MEDS study is a 5-year, randomized controlled clinical intervention trial comparing a patient-centered describing intervention with usual care among older (≥50 years) hospitalized patients discharged to PAC, either a skilled nursing facility (SNF) or an inpatient rehabilitation facility (IPR). Patient measurements occur at hospital enrollment, hospital discharge, within 7 days of PAC discharge, and at 60 and 90 days following PAC discharge. Patients are randomized in a permuted block fashion, with block sizes of two to four. The overall effectiveness of the intervention will be evaluated using total medication count as the primary outcome measure. We estimate that 576 patients will enroll in the study. Following attrition due to death or loss to follow-up, 420 patients will contribute measurements at 90 days, which provides 90% power to detect a 30% versus 25% reduction in total medications with an alpha error of 0.05. Secondary outcomes include the number of medications associated with geriatric syndromes, drug burden index, medication adherence, the prevalence and severity of geriatric syndromes and functional health status.

Discussion: The Shed-MEDS trial aims to test the hypothesis that a patient-centered deprescribing intervention initiated in the hospital and continuing through the PAC stay will reduce the total number of medications 90 days following PAC discharge and result in improvements in geriatric syndromes and functional health status. The results of this trial will quantify the health outcomes associated with reducing medications for hospitalized older adults with polypharmacy who are discharged to post-acute care facilities.

Trial Registration: This trial was prospectively registered at clinicaltrials.gov ( NCT02979353 ). The trial was first registered on 12/1/2016, with an update on 09/28/17 and 10/12/2018.

Citing Articles

A systematic review of outcomes reported in studies to optimise the medication use of patients at hospital discharge.

Wuyts J, Foulon V, Allemann S, Boeni F BMC Health Serv Res. 2025; 25(1):135.

PMID: 39849488 PMC: 11758755. DOI: 10.1186/s12913-024-12024-6.


Fall Outcomes in Older Adults Following Benzodiazepine/Z-Drug Discontinuation: A Retrospective Cohort Study in an Academic Health System.

Schindler N, Zepel L, Maciejewski M, Hastings S, Clark A, Dublin S Drugs Aging. 2024; 41(10):809-819.

PMID: 39292394 DOI: 10.1007/s40266-024-01144-7.


Current Landscape and Future Directions of Deprescribing and Polypharmacy Practices in Jordan.

Barakat M, Nassar R, Gharaibeh L, Thiab S, Nashwan A Med Princ Pract. 2024; 33(6):505-518.

PMID: 39159605 PMC: 11631112. DOI: 10.1159/000541009.


Medication Discrepancies among Older Hospitalized Adults Discharged from Post-Acute Care Facilities to Home.

Vasilevskis E, Trumbo S, Shah A, Hollingsworth E, Shotwell M, Mixon A J Am Med Dir Assoc. 2024; 25(7):105017.

PMID: 38754476 PMC: 11335011. DOI: 10.1016/j.jamda.2024.105017.


Emergency department visits and hospital readmissions after a deprescribing intervention among hospitalized older adults.

Lee J, Hollingsworth E, Shah A, Szanton S, Perrin N, Mixon A J Am Geriatr Soc. 2024; 72(7):2038-2047.

PMID: 38725307 PMC: 11226369. DOI: 10.1111/jgs.18945.


References
1.
Wilson N, Hilmer S, March L, Cameron I, Lord S, Seibel M . Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc. 2011; 59(5):875-80. DOI: 10.1111/j.1532-5415.2011.03386.x. View

2.
Geijteman E, van Gelder T, van Zuylen L . Sense and nonsense of treatment of comorbid diseases in terminally ill patients. JAMA Intern Med. 2015; 175(3):346. DOI: 10.1001/jamainternmed.2014.7592. View

3.
Gormley E, Griffiths D, McCracken P, Harrison G . Polypharmacy and its effect on urinary incontinence in a geriatric population. Br J Urol. 1993; 71(3):265-9. DOI: 10.1111/j.1464-410x.1993.tb15940.x. View

4.
Walter L, Brand R, Counsell S, Palmer R, Landefeld C, Fortinsky R . Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA. 2001; 285(23):2987-94. DOI: 10.1001/jama.285.23.2987. View

5.
Nishtala P, Narayan S, Wang T, Hilmer S . Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014; 23(7):753-8. DOI: 10.1002/pds.3624. View